Viewing Study NCT05915351


Ignite Creation Date: 2025-12-24 @ 11:52 PM
Ignite Modification Date: 2025-12-25 @ 9:48 PM
Study NCT ID: NCT05915351
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-04-16
First Post: 2023-05-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Enfortumab Vedotin in Previously Treated Locally Advanced or Metastatic Pancreatic Cancer (EPIC)
Sponsor: University of Kansas Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module